GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List

Range Low Price High Price Comment
30 days $1.88 $3.18 Friday, 19th Apr 2024 GLYC stock ended at $1.93. This is 10.88% less than the trading day before Thursday, 18th Apr 2024. During the day the stock fluctuated 15.43% from a day low at $1.88 to a day high of $2.17.
90 days $1.88 $3.53
52 weeks $1.11 $3.53

Historical GlycoMimetics prices

Date Open High Low Close Volume
2024-04-19 $2.17 $2.17 $1.88 $1.93 1 163 238
2024-04-18 $2.29 $2.36 $2.15 $2.16 875 938
2024-04-17 $2.16 $2.39 $2.16 $2.28 843 023
2024-04-16 $2.24 $2.33 $2.14 $2.15 598 403
2024-04-15 $2.40 $2.47 $2.23 $2.26 763 570
2024-04-12 $2.50 $2.53 $2.32 $2.40 520 071
2024-04-11 $2.57 $2.57 $2.48 $2.51 479 032
2024-04-10 $2.68 $2.73 $2.42 $2.45 957 161
2024-04-09 $2.62 $2.71 $2.59 $2.68 761 164
2024-04-08 $2.81 $2.81 $2.56 $2.59 697 473
2024-04-05 $2.81 $2.83 $2.66 $2.75 391 442
2024-04-04 $2.79 $2.86 $2.68 $2.71 394 511
2024-04-03 $3.00 $3.02 $2.72 $2.77 580 094
2024-04-02 $3.01 $3.16 $2.91 $2.96 391 526
2024-04-01 $3.06 $3.14 $3.00 $3.04 719 406
2024-03-28 $3.10 $3.11 $2.90 $3.00 648 027
2024-03-27 $2.91 $3.18 $2.81 $3.18 674 297
2024-03-26 $2.86 $2.89 $2.80 $2.85 225 162
2024-03-25 $2.97 $3.02 $2.77 $2.82 319 890
2024-03-22 $2.90 $3.02 $2.85 $2.93 205 430
2024-03-21 $3.03 $3.14 $2.87 $2.88 284 382
2024-03-20 $2.96 $3.10 $2.88 $3.05 627 502
2024-03-19 $2.78 $3.02 $2.77 $2.93 430 814
2024-03-18 $2.61 $2.87 $2.58 $2.80 468 185
2024-03-15 $2.64 $2.69 $2.54 $2.56 242 121
Click to get the best stock tips daily for free!

About GlycoMimetics

GlycoMimetics GlycoMimetics, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in the United States. It is developing uproleselan, an E-selectin inhibitor, which is used in combination with chemotherapy to treat acute myeloid leukemia (AML), as well as in phase 3 trial to treat relapsed/refractory AML. In addition, the company is developing G... GLYC Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT